Remove Big Data Remove Business Development Remove Development
article thumbnail

How Big Data will accelerate the future of digital medicine in 2021

pharmaphorum

Jennifer Haas, executive vice president of Noteworth, shares her 2021 predictions surrounding the future of telehealth and big data. . The ability to use big data in healthcare through digital medicine will prove to be invaluable for healthcare organisations as they work through the pandemic and the new world it has created.

Big Data 111
article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

His research focuses on the development of big data machine learning for tracking the health of complex systems. He has carried a drug candidate continuously from early preclinical development throughout to market authorisation with an innovative application strategy, including a novel and innovative real-world data approach.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The new technologies strengthening pharmaceutical supply chains

Pharmaceutical Technology

According to a recent GlobalData report, healthcare professionals have – for the second year in a row – ranked artificial intelligence (AI) and Big Data as the top two technologies revolutionising the pharmaceutical sector. Access to detailed data in real time enables firms to track and optimize product storage and distribution.

Big Data 130
article thumbnail

SMi’s 3rd Annual AI in Drug Discovery Conference

pharmaphorum

Exploring the Impact of Machine Learning and Artificial Intelligence in Drug Development from Discovery to Healthcare. AI in drug discovery is becoming an integral part of the research and development area of treating diseases with more companies incorporating ‘Big Data’ and data scientists within their R&D teams.

Drugs 52
article thumbnail

Empowering rare disease patient advocacy organisations with data

pharmaphorum

Instead, Komodo’s software is the gateway to the Map’s data. One is the platform, which is essentially what our internal solution developers capitalise on, and then we externalise that capability to third-party developers.”. The business of data. Our software is deployed across two dimensions. About the author.

article thumbnail

Using technology to reassess the clinical trial landscape

pharmaphorum

The company developed the first FDA-authorised at-home VR pain treatment, RelieVRx, indicated as an adjunctive treatment for chronic lower back pain. He oversees operations, including business development, sales and marketing, and people. Distinct offerings. AppliedVR creates VR-based treatments aimed at relieving chronic pain.

article thumbnail

Kiromic Announces the Filing of Key European Patents for Its Chimeric PD-1 (chPD1) Target

The Pharma Data

Kiromic’s deep understanding of the tumor micro environment (TME) and the tumors’ escape and masking mechanisms led to development of a promising platform for chimeric antigen receptor therapy (CAR-T). PD-1 has always been a challenge for CAR-T development. “We believe Prof. About PD-1 Check-point inhibition.

In-Vivo 40